FTSE 350 Pharmaceuticals & Biotechnology Index (NMX4570) Companies by Market Cap

The FTSE 350 Pharmaceuticals & Biotechnology Index (NMX4570) tracks 6 constituent companies with a combined market cap of $3.20 Billion, covering the largest publicly traded companies in UK. This ranking lists all NMX4570 index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.

Total Market Cap (USD)

$3.20 Billion

Constituent Companies

6

Index Country

UK
Rank Company Weight (%) Market Cap (USD) Sector Industry Price 24h Change
1 AstraZeneca PLC
LSE:AZN
% $2.26 Billion Healthcare Drug Manufacturers - General GBX11998.00 +0.89%
2 GSK plc
LSE:GSK
% $853.19 Million Healthcare Drug Manufacturers - General GBX1750.00 +0.84%
3 Hikma Pharmaceuticals PLC
LSE:HIK
% $43.43 Million Healthcare Drug Manufacturers - Specialty & Generic GBX1612.00 +0.31%
4 Indivior PLC
LSE:INDV
% $18.79 Million Healthcare Drug Manufacturers - Specialty & Generic GBX1238.00 +0.00%
5 Genus PLC
LSE:GNS
% $18.42 Million Healthcare Biotechnology GBX2280.00 +2.61%
6
Dechra Pharmaceuticals PLC
LSE:DPH
% - Healthcare Drug Manufacturers - General - -

Complete list of all companies in the NMX4570 index ranked by market capitalization. Track index constituent performance and market values. View all indices